Le Cao1, Ju Yu1. 1. Institute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK-Shenzhen Research Institute, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China.
Abstract
BACKGROUND: Gastric cancer is one of the most common cancer types worldwide. In China, gastric cancer has become one of the major threats for public health, ranking second on incidence and third on cause of cancer death. Despite the common risk factors that promote the development of gastric cancer, the huge quantity of microorganism colonies within the gastrointestinal tract, particularly Helicobacter pylori infection, demonstrates a correlation with chronic inflammation and gastric carcinogenesis, as epidemiological studies have determined that H. pylori infection confers approximately 75% of the attributable risk for gastric cancer. SUMMARY: The current article draws an overview on the correlation between the microbiota, inflammation and gastric tumorigenesis. H. pylori infection has been identified as the main risk factor as it triggers epithelial barrier disruption, survival signaling as well as genetic/epigenetic modulation. Apart from H. pylori, the existence of a diverse and complex composition of microbiota in the stomach has been identified, which supports a role of microbiota in the development of gastric cancer. Moreover, metagenomics studies focused on the composition and function of the microbiota have associated microbiota with gastric metabolic diseases and even tumorigenesis. Apart from the gastric microbiota, inflammation is another identified contributor to cancer development as well. KEY MESSAGE: Though H. pylori infection and the non-H. pylori microbiota play a role in gastric cancer, the properties of gastric microbiota and mechanisms by which they participate in the genesis of gastric cancer are still not clearly depicted. Moreover, it remains to be understood how the presence of microbiota along with H. pylori infection affects the progress from gastric disease to cancer. PRACTICAL IMPLICATIONS: This article summarized a clue of the current studies on microbiota, H. pylori infection and the progression from gastric disease to cancer.
BACKGROUND:Gastric cancer is one of the most common cancer types worldwide. In China, gastric cancer has become one of the major threats for public health, ranking second on incidence and third on cause of cancer death. Despite the common risk factors that promote the development of gastric cancer, the huge quantity of microorganism colonies within the gastrointestinal tract, particularly Helicobacter pyloriinfection, demonstrates a correlation with chronic inflammation and gastric carcinogenesis, as epidemiological studies have determined that H. pyloriinfection confers approximately 75% of the attributable risk for gastric cancer. SUMMARY: The current article draws an overview on the correlation between the microbiota, inflammation and gastric tumorigenesis. H. pyloriinfection has been identified as the main risk factor as it triggers epithelial barrier disruption, survival signaling as well as genetic/epigenetic modulation. Apart from H. pylori, the existence of a diverse and complex composition of microbiota in the stomach has been identified, which supports a role of microbiota in the development of gastric cancer. Moreover, metagenomics studies focused on the composition and function of the microbiota have associated microbiota with gastric metabolic diseases and even tumorigenesis. Apart from the gastric microbiota, inflammation is another identified contributor to cancer development as well. KEY MESSAGE: Though H. pyloriinfection and the non-H. pylori microbiota play a role in gastric cancer, the properties of gastric microbiota and mechanisms by which they participate in the genesis of gastric cancer are still not clearly depicted. Moreover, it remains to be understood how the presence of microbiota along with H. pyloriinfection affects the progress from gastric disease to cancer. PRACTICAL IMPLICATIONS: This article summarized a clue of the current studies on microbiota, H. pyloriinfection and the progression from gastric disease to cancer.
Authors: N Murata-Kamiya; Y Kurashima; Y Teishikata; Y Yamahashi; Y Saito; H Higashi; H Aburatani; T Akiyama; R M Peek; T Azuma; M Hatakeyama Journal: Oncogene Date: 2007-01-22 Impact factor: 9.867
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Claudio Durán; Sara Ciucci; Alessandra Palladini; Umer Z Ijaz; Antonio G Zippo; Francesco Paroni Sterbini; Luca Masucci; Giovanni Cammarota; Gianluca Ianiro; Pirjo Spuul; Michael Schroeder; Stephan W Grill; Bryony N Parsons; D Mark Pritchard; Brunella Posteraro; Maurizio Sanguinetti; Giovanni Gasbarrini; Antonio Gasbarrini; Carlo Vittorio Cannistraci Journal: Nat Commun Date: 2021-03-26 Impact factor: 14.919
Authors: Zhongming Ge; Alexander Sheh; Yan Feng; Sureshkumar Muthupalani; Lili Ge; Chuanwu Wang; Susanna Kurnick; Anthony Mannion; Mark T Whary; James G Fox Journal: Sci Rep Date: 2018-05-22 Impact factor: 4.379
Authors: George V Tetz; Kelly V Ruggles; Hua Zhou; Adriana Heguy; Aristotelis Tsirigos; Victor Tetz Journal: Sci Rep Date: 2017-08-01 Impact factor: 4.379